Vanguard Group
ARVN icon

Vanguard Group’s Arvinas ARVN Stock Holding History

Vanguard Group’s Portfolio ARVN Stock Details ARVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$85.7M Sell
7,229,603
-1,331,629
-16% -$14.5M ﹤0.01% 1933
2025
Q3 		$72.9M Sell
8,561,232
-831,929
-9% -$6.31M ﹤0.01% 1983
2025
Q2 		$69.1M Buy
9,393,161
+1,030,961
+12% +$7.59M ﹤0.01% 1980
2025
Q1 		$58.7M Buy
8,362,200
+1,299,639
+18% +$20.4M ﹤0.01% 2031
2024
Q4 		$135M Buy
7,062,561
+56,561
+0.8% +$1.37M ﹤0.01% 1720
2024
Q3 		$173M Buy
7,006,000
+334,179
+5% +$8.73M ﹤0.01% 1619
2024
Q2 		$178M Buy
6,671,821
+372,265
+6% +$11.9M ﹤0.01% 1554
2024
Q1 		$260M Buy
6,299,556
+1,448,166
+30% +$63.3M 0.01% 1362
2023
Q4 		$200M Buy
4,851,390
+243,167
+5% +$5.68M ﹤0.01% 1505
2023
Q3 		$90.5M Buy
4,608,223
+90,426
+2% +$2.22M ﹤0.01% 1859
2023
Q2 		$112M Buy
4,517,797
+23,873
+0.5% +$614K ﹤0.01% 1795
2023
Q1 		$123M Buy
4,493,924
+36,667
+0.8% +$1.16M ﹤0.01% 1723
2022
Q4 		$152M Buy
4,457,257
+277,192
+7% +$11.7M ﹤0.01% 1580
2022
Q3 		$186M Buy
4,180,065
+116,877
+3% +$5.67M 0.01% 1427
2022
Q2 		$171M Buy
4,063,188
+39,607
+1% +$1.99M ﹤0.01% 1526
2022
Q1 		$271M Buy
4,023,581
+31,372
+0.8% +$2.14M 0.01% 1351
2021
Q4 		$328M Buy
3,992,209
+191,277
+5% +$15.6M 0.01% 1276
2021
Q3 		$312M Buy
3,800,932
+129,320
+4% +$11.4M 0.01% 1299
2021
Q2 		$283M Buy
3,671,612
+1,108,848
+43% +$77M 0.01% 1407
2021
Q1 		$169M Buy
2,562,764
+820,976
+47% +$62.8M ﹤0.01% 1667
2020
Q4 		$148M Buy
1,741,788
+494,711
+40% +$17.1M ﹤0.01% 1631
2020
Q3 		$29.4M Buy
1,247,077
+148,715
+14% +$4.31M ﹤0.01% 2282
2020
Q2 		$36.8M Buy
1,098,362
+176,150
+19% +$7.48M ﹤0.01% 2151
2020
Q1 		$37.2M Buy
922,212
+33,580
+4% +$1.57M ﹤0.01% 1999
2019
Q4 		$36.5M Buy
888,632
+272,445
+44% +$7.98M ﹤0.01% 2248
2019
Q3 		$13.3M Buy
616,187
+70,882
+13% +$1.74M ﹤0.01% 2679
2019
Q2 		$12M Buy
545,305
+135,177
+33% +$2.84M ﹤0.01% 2751
2019
Q1 		$6.05M Buy
410,128
+61,993
+18% +$1.1M ﹤0.01% 3070
2018
Q4 		$4.47M Buy
+348,135
New +$5.52M ﹤0.01% 3127

Other funds holding ARVN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Vanguard Group's ARVN Position: Q4 2025 in Review

Vanguard Group reduced its Arvinas (ARVN) stake by 16% in Q4 2025, selling an estimated $14.5M and leaving 7,229,603 shares worth $85.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1933.

Vanguard Group first reported a position in ARVN in Q4 2018 and has held it in 29 quarters since. The position peaked at $328M in Q4 2021. 205 funds tracked by Wall St. Rank hold ARVN as of Q4 2025.

  • Vanguard Group held 7,229,603 shares of Arvinas worth $85.7M as of Q4 2025.
  • Vanguard Group sold 1,331,629 Arvinas shares in Q4 2025, an estimated $14.5M.
  • Arvinas made up ﹤0.01% of Vanguard Group's portfolio in Q4 2025, its #1933 holding.
  • Vanguard Group first reported a position in Arvinas in Q4 2018 and has held it in 29 quarters since.
  • Vanguard Group's Arvinas position peaked at $328M in Q4 2021.
  • 205 funds tracked by Wall St. Rank held Arvinas as of Q4 2025.

Based on Vanguard Group's 13F filing for Q4 2025, filed 29 Jan 2026.